{"id":3032,"date":"2013-11-12T21:45:00","date_gmt":"2013-11-12T21:45:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=3032"},"modified":"2025-01-16T15:59:13","modified_gmt":"2025-01-16T15:59:13","slug":"the-new-paradigm-of-hepatitis-c-therapy-integration-of-oral-therapies-into-best-practices","status":"publish","type":"post","link":"https:\/\/cdafound.org\/fr\/the-new-paradigm-of-hepatitis-c-therapy-integration-of-oral-therapies-into-best-practices\/","title":{"rendered":"Le nouveau paradigme de la th\u00e9rapie contre l&#039;h\u00e9patite C: int\u00e9gration des th\u00e9rapies orales dans les meilleures pratiques"},"content":{"rendered":"<h2 class=\"wp-block-heading\">R\u00e9sum\u00e9<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Collaborateurs<\/h3>\n\n\n\n<p><strong>Nouveau paradigme des participants \u00e0 la r\u00e9union sur la th\u00e9rapie du VHC<\/strong>: Nezam H Afdhal, Rachel Baden, Cynthia Beam, Julie Krop, Clifford Brass, David Brumley, Laurent Castera, Daniel Church, Alfred DeMaria Jr, Kevin Cranston, Lynda Dee, Arnold Doyle, Julia Engstrom-Melnyk, Michael Fried, Camilla Graham, Michael Wong, William Guyer, John G McHutchison, Joe Steele, William Symonds, Ira M Jacobson, Alain Litwin, Anthony Martinez, Andrew Talal, Henry Masur, Douglas Mayers, Ronald C Renaud Jr, Shruti H Mehta, Andrew Muir, Christopher J Myatt , Stanley J Naides, Rick Pesano, William O&#039;Brien, Christos J Petropoulos, Gast\u00f3n R Picchio, Thierry Poynard, Avi Prabhakar, Kellie A Rademacher, Homie Razavi, Gary Rice, Robert Schooley, David Wyles, Joseph Sebastian, Bryce D Smith, John Ward, Mark Sulkowski, David Thomas, Chris Taylor, Stefan Zeuzem<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Abstrait<\/h3>\n\n\n\n<p>De nouvelles donn\u00e9es indiquent que les traitements antiviraux tout oraux contre le virus de l&#039;h\u00e9patite C chronique (VHC) deviendront une r\u00e9alit\u00e9 dans un proche avenir. En rempla\u00e7ant les th\u00e9rapies \u00e0 base d&#039;interf\u00e9ron, on s&#039;attend \u00e0 ce que les r\u00e9gimes tout oraux soient plus tol\u00e9rables, plus efficaces, plus courts et plus simples \u00e0 administrer. De nouvelles m\u00e9thodes de d\u00e9pistage et de stadification de la maladie co\u00efncident avec de nouvelles options de traitement, ce qui cr\u00e9e la possibilit\u00e9 de soins et de traitements plus rapides. Les \u00e9valuations des dommages histologiques sont g\u00e9n\u00e9ralement effectu\u00e9es \u00e0 l&#039;aide d&#039;une biopsie h\u00e9patique, mais les \u00e9valuations non invasives des dommages histologiques sont devenues la norme dans certains pays europ\u00e9ens et sont de plus en plus r\u00e9pandues aux \u00c9tats-Unis. De nouvelles initiatives des Centers for Disease Control and Prevention (CDC) sont \u00e9galement en place pour simplifier les tests, am\u00e9liorer la sensibilisation des prestataires et des patients et \u00e9largir les recommandations pour le d\u00e9pistage du VHC au-del\u00e0 des strat\u00e9gies fond\u00e9es sur les risques. \u00c9mises en 2012, les recommandations des CDC visent \u00e0 augmenter le d\u00e9pistage du VHC parmi les personnes les plus touch\u00e9es par le VHC aux \u00c9tats-Unis en recommandant des tests uniques pour toutes les personnes n\u00e9es entre 1945-1965. En 2013, le Groupe de travail sur les services de pr\u00e9vention des \u00c9tats-Unis a adopt\u00e9 des recommandations similaires pour les tests bas\u00e9s sur le risque et sur la cohorte de naissance. Pris ensemble, les d\u00e9veloppements en mati\u00e8re de d\u00e9pistage, de diagnostic et de traitement augmenteront probablement la demande de th\u00e9rapie et stimuleront un changement dans la prestation des soins li\u00e9s au VHC chronique, avec une participation accrue des sp\u00e9cialistes des soins primaires et des maladies infectieuses. Pourtant, m\u00eame dans cette nouvelle \u00e8re de th\u00e9rapie, des obstacles \u00e0 la gu\u00e9rison des patients atteints du VHC existeront. Pour surmonter ces obstacles, il faudra de nouvelles strat\u00e9gies int\u00e9gratives et un investissement de ressources aux niveaux local, r\u00e9gional et national.<\/p>\n\n\n\n<p><strong>Des pays:<\/strong> \u00c9tats Unis<\/p>\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link has-text-color wp-element-button\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24168254\/\" target=\"_blank\" rel=\"noreferrer noopener\">Lire le rapport complet<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Summary Collaborators New Paradigm of HCV Therapy Meeting Participants:&nbsp;Nezam H Afdhal,&nbsp;Rachel Baden,&nbsp;Cynthia Beam,&nbsp;Julie Krop,&nbsp;Clifford Brass,&nbsp;David Brumley,&nbsp;Laurent Castera,&nbsp;Daniel Church,&nbsp;Alfred DeMaria Jr,&nbsp;Kevin Cranston,&nbsp;Lynda Dee,&nbsp;Arnold Doyle,&nbsp;Julia Engstrom-Melnyk,&nbsp;Michael Fried,&nbsp;Camilla Graham,&nbsp;Michael Wong,&nbsp;William Guyer,&nbsp;John G McHutchison,&nbsp;Joe Steele,&nbsp;William Symonds,&nbsp;Ira M Jacobson,&nbsp;Alain Litwin,&nbsp;Anthony Martinez,&nbsp;Andrew Talal,&nbsp;Henry Masur,&nbsp;Douglas Mayers,&nbsp;Ronald C Renaud Jr,&nbsp;Shruti H Mehta,&nbsp;Andrew Muir,&nbsp;Christopher J Myatt,&nbsp;Stanley J Naides,&nbsp;Rick Pesano,&nbsp;William O&#8217;Brien,&nbsp;Christos J Petropoulos,&nbsp;Gast\u00f3n R Picchio,&nbsp;Thierry [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":3193,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[10],"publication-author":[2294,2302,2307,2298,2304,2305,2295,2297,2296,2308,2299,494,2301,2306,2303,2300,2176,616],"class_list":["post-3032","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-hcv","publication-author-afdhal-nh","publication-author-castera-l","publication-author-church-dr","publication-author-dee-l","publication-author-graham-c","publication-author-jacobson-im","publication-author-litwin-ah","publication-author-mehta-sh","publication-author-muir-a","publication-author-new-paradigm-of-hcv-therapy-meeting-participants","publication-author-poynard-t","publication-author-razavi-h","publication-author-schooley-rt","publication-author-sulkowski-ms","publication-author-talal-ah","publication-author-thomas-dl","publication-author-ward-jw","publication-author-zeuzem-s"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/3032","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/comments?post=3032"}],"version-history":[{"count":5,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/3032\/revisions"}],"predecessor-version":[{"id":7643,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/3032\/revisions\/7643"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media\/3193"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media?parent=3032"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/categories?post=3032"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/tags?post=3032"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/publication-author?post=3032"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}